Dr. Robert M Olson Iii, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 251 N Hwy 173, Lake Arrowhead, CA 92321 Phone: 909-336-3670 Fax: 909-336-3674 |
News Archive
A small war has erupted over the recent Congressional Budget Office report on the employment effects of the Affordable Care Act. Last week, the CBO itself felt compelled to offer a lengthy and detailed rebuttal to the spin that millions of Americans will "lose their jobs" as a result of Obamacare.
Today at the Frankfurt International Motor Show, Pilkington Group Limited announced that it has acquired a new license from Research Frontiers Inc. to offer SPD-Smart automotive end-products globally.
Some E. coli bacteria are harmless and some are dangerous from the outset. Then some become dangerous when they are subjected to viral infection. Researchers are working to find tools that will reduce the risk of this happening.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
The cholesterol-lowering drug atorvastatin slowed down mental decline and improved depressive symptoms in people with Alzheimer's disease, according to a small pilot study reported at the American Heart Association's Scientific Sessions 2004.
› Verified 6 days ago